Targeting HMGB2 acts as dual immunomodulator by bolstering CD8 + T cell function and inhibiting tumor growth in hepatocellular carcinoma
Wei‐Feng Qu, Gui‐Qi Zhu, Tian-Hao Chu, Run Huang et autres
11 citationsScience Advances
Tian-Hao Chu
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
6Publications signalées
130Citations signalées
5Affiliations récentes
Institutions déclarées
Domaines associés
Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisPancreatic and Hepatic Oncology ResearchImmunotherapy and Immune Responses
Publications récentes
Targeting SRSF1 improves cancer immunotherapy by dually acting on CD8+T and tumor cells
Gui‐Qi Zhu, Zheng Tang, Tian-Hao Chu, Biao Wang et autres
19 citationsSignal Transduction and Targeted Therapy
Downregulation of GPX8 in hepatocellular carcinoma: impact on tumor stemness and migration
Chenyang Tao, Xiaoling Wu, Shushu Song, Zheng Tang et autres
3 citationsCellular Oncology
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
Yi Wang, Gui‐Qi Zhu, Rui Yang, Cheng Wang et autres
36 citationsJournal of Translational Medicine
Deciphering intratumoral heterogeneity of hepatocellular carcinoma with microvascular invasion with radiogenomic analysis
Yi Wang, Gui‐Qi Zhu, Rui Yang, Cheng Wang et autres
3 citationsResearch Square
Development of a deep pathomics score for predicting hepatocellular carcinoma recurrence after liver transplantation
Wei‐Feng Qu, Meng‐Xin Tian, Hongwei Lü, Yufu Zhou et autres
58 citationsHepatology International
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.